Top Markets
#1 Siren Siren +33.28%
#2 Wiki Cat Wiki Cat +24.73%
#3 TRIA TRIA +20.33%
#4 Ribbita by Virtuals Ribbita by Virtuals +17.28%
#5 PulseChain PulseChain +16.92%
#6 Bitway Bitway +14.90%
#7 Nockchain Nockchain +14.88%
#8 KUB Coin KUB Coin +14.59%
#9 Velvet Velvet +14.59%
#10 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +14.56%
Coin of the day
Siren Siren
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
FunPep Company Limited FunPep Company Limited

FunPep Company Limited

4881
Classement en actions #30950
FunPep Company Limited specializes in the discovery and advancement of... FunPep Company Limited specializes in the discovery and advancement of pharmaceutical drugs, functional cosmetics, and medical devices, leveraging its core technology in functional peptides. The company's development pipeline prominently features SR-0379, a functional peptide designed to address skin ulcers. FunPep is advancing FPP003, an antibody-inducing peptide, which is undergoing Phase II clinical trials for psoriasis in Australia and for ankylosing spondylitis in Japan. Another antibody-inducing peptide, FPP004X, is also in development, targeting pollinosis. Additionally, the company is working on FPP006, a corona peptide vaccine, and FPP005, an antibody-inducing peptide for psoriasis. Established in 2013, FunPep Company Limited operates from its headquarters in Tokyo, Japan.
Prix de l'action
$0.33274288
Capitalisation boursière
$14.92M
Changement (1 jour)
2.00%
Changement (1 an)
-57.59%
Pays
JP
Échange FunPep Company Limited (4881)

Catégorie

Healthcare
Ratio P/B pour FunPep Company Limited (4881)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de FunPep Company Limited, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour FunPep Company Limited de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE